The 3 linked references in paper A. Mosikian A., W. Zhao, T. Galankin L., A. Kolbin S., А. Мосикян А., В. Чжао, А. Галанкин С., А. Колбин С. (2017) “Особенности симуляционного моделирования при оценке клинико-экономических исходов сахарного диабета 1-го и 2-го типов // Decision modelling for the evaluation of diabetes outcomes” / spz:neicon:pharmacoeconomics:y:2017:i:3:p:47-58

  1. Briggs A., Claxton C., Sculpher M. Decision modelling for health economic evaluation. Oxford University Press, 2006.
  2. Henriksson M., Jindal R., Sternhufvud C. et al. A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus. Pharmacoeconomics (in Russian). 2016; 34 (6): 569-85.
  3. National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. NICE guidelines [NG28]. URL: https://www. nice.org.uk/guidance/ng28. Accessed: 19.07.2017.